[1]
A. Sobczak, M. Kowalczyk, M. Wolff, K. Kreft, L. Głuszkiewicz, and A. Waldman, “Impact of Commercialisation of Extreme Mountaineering on High-Altitude Hypoxia, Pharmacological Prophylaxis, and Risk Management on Mount Everest: A Narrative Review”, Qual Sport, vol. 76, p. 75522, Sep. 2026.